NARCA: A novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NARCA: A novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer
Authors
Keywords
-
Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-09-10
DOI
10.1002/jso.25209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The neutrophil to albumin ratio as a predictor of pathological complete response in rectal cancer patients following neoadjuvant chemoradiation
- (2016) Bernard Tawfik et al. ANTI-CANCER DRUGS
- Evaluation of Modified Glasgow Prognostic Score for Pancreatic Cancer
- (2016) Hiroshi Imaoka et al. PANCREAS
- Targeting inflammation in pancreatic cancer: Clinical translation
- (2016) Colin William Steele et al. World Journal of Gastrointestinal Oncology
- Hyperfibrinogen Is Associated With the Systemic Inflammatory Response and Predicts Poor Prognosis in Advanced Pancreatic Cancer
- (2015) Qi Qi et al. PANCREAS
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- Blood Neutrophil–Lymphocyte Ratio Predicts Survival in Patients with Advanced Pancreatic Cancer Treated with Chemotherapy
- (2014) Guopei Luo et al. ANNALS OF SURGICAL ONCOLOGY
- Cancer and systemic inflammation: treat the tumour and treat the host
- (2014) C S D Roxburgh et al. BRITISH JOURNAL OF CANCER
- Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer
- (2014) H. L. Martin et al. INTERNAL MEDICINE JOURNAL
- Exploiting inflammation for therapeutic gain in pancreatic cancer
- (2013) C W Steele et al. BRITISH JOURNAL OF CANCER
- Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
- (2013) M Stotz et al. BRITISH JOURNAL OF CANCER
- The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer
- (2013) Haiyan Wang et al. PLATELETS
- The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
- (2012) Donald C. McMillan CANCER TREATMENT REVIEWS
- Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer
- (2012) De-shen Wang et al. MEDICAL ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone
- (2009) H S Wasan et al. BRITISH JOURNAL OF CANCER
- Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
- (2008) Richard A. Smith et al. AMERICAN JOURNAL OF SURGERY
- CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial
- (2008) Viviane Hess et al. LANCET ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started